Why is the oral cholera vaccine not considered an option for prevention of cholera in India? Analysis of possible reasons.
作者信息
Gupta Sanjukta Sen, Bharati Kaushik, Sur Dipika, Khera Ajay, Ganguly N K, Nair G Balakrish
机构信息
Translational Health Science & Technology Institute, Faridabad 121 001, Haryana, India.
Ministry of Health & Family Welfare, Government of India, New Delhi 110 011, India.
出版信息
Indian J Med Res. 2016 May;143(5):545-51. doi: 10.4103/0971-5916.187102.
Abstract
摘要
相似文献
1
Why is the oral cholera vaccine not considered an option for prevention of cholera in India? Analysis of possible reasons.为什么口服霍乱疫苗在印度不被视为预防霍乱的一种选择？对可能原因的分析。
Indian J Med Res. 2016 May;143(5):545-51. doi: 10.4103/0971-5916.187102.
2
Cholera vaccine inactivated oral.口服霍乱灭活疫苗
Drugs R D. 1999 Sep;2(3):193-4. doi: 10.2165/00126839-199902030-00007.
3
High hopes for oral cholera vaccine.口服霍乱疫苗寄予厚望。
Bull World Health Organ. 2010 Mar;88(3):165-6. doi: 10.2471/BLT.10.010310.
4
An oral cholera vaccine for travelers (Vaxchora).一种用于旅行者的口服霍乱疫苗（Vaxchora）。
Med Lett Drugs Ther. 2016 Aug 29;58(1502):113-4.
5
Prevention of cholera.霍乱的预防
Lancet. 2004 Mar 13;363(9412):898. doi: 10.1016/S0140-6736(04)15749-8.
6
The opportunities & challenges in delivering oral cholera vaccines.口服霍乱疫苗接种中的机遇与挑战
Indian J Med Res. 2016 Aug;144(2):149-150. doi: 10.4103/0971-5916.194997.
7
Efficacy of a live oral cholera vaccine in human volunteers.一种口服霍乱活疫苗在人体志愿者中的效力
Dev Biol Stand. 1976;33:108-12.
8
Non-O1 Vibrio cholerae and epidemic cholera.非O1群霍乱弧菌与流行性霍乱
Commun Dis Rep CDR Wkly. 1993 Jun 11;3(24):107.
9
Construction of novel vaccine strains of Vibrio cholerae co-expressing the Inaba and Ogawa serotype antigens.构建同时表达 Inaba 和 Ogawa 血清型抗原的新型霍乱弧菌疫苗株。
Vaccine. 2011 Oct 6;29(43):7505-13. doi: 10.1016/j.vaccine.2011.06.121. Epub 2011 Jul 30.
10
Cholera vaccines.霍乱疫苗
Lancet Infect Dis. 2007 Mar;7(3):176-8; author reply 178. doi: 10.1016/S1473-3099(07)70032-4.
引用本文的文献
1
Sodium butyrate inhibits the expression of virulence factors in by targeting ToxT protein.丁酸钠通过靶向ToxT蛋白抑制霍乱弧菌毒力因子的表达。 （注：原文中“in by targeting”表述有误，推测是“in Vibrio cholerae by targeting”，译文按此推测翻译）
mSphere. 2025 May 27;10(5):e0082424. doi: 10.1128/msphere.00824-24. Epub 2025 Apr 22.
2
Analysis of Cholera Risk in India: Insights from 2017-18 Serosurvey Data Integrated with Epidemiologic data and Societal Determinants from 2015-2019.分析印度的霍乱风险：2015-2019 年流行病学数据和社会决定因素综合 2017-2018 年血清学调查数据得出的见解。
PLoS Negl Trop Dis. 2024 Sep 3;18(9):e0012450. doi: 10.1371/journal.pntd.0012450. eCollection 2024 Sep.
3
Non-Canonical Host Intracellular Niche Links to New Antimicrobial Resistance Mechanism.非经典宿主细胞内生态位与新的抗菌耐药机制相关。
Pathogens. 2022 Feb 8;11(2):220. doi: 10.3390/pathogens11020220.
4
Climate Precursors of Satellite Water Marker Index for Spring Cholera Outbreak in Northern Bay of Bengal Coastal Regions.孟加拉湾北部沿海地区春季霍乱卫星水标记指数的气候前兆。
Int J Environ Res Public Health. 2021 Sep 28;18(19):10201. doi: 10.3390/ijerph181910201.
5
Cholera Risk: A Machine Learning Approach Applied to Essential Climate Variables.霍乱风险：应用于基本气候变量的机器学习方法。
Int J Environ Res Public Health. 2020 Dec 15;17(24):9378. doi: 10.3390/ijerph17249378.
6
Glucose Metabolism by Escherichia coli Inhibits Vibrio cholerae Intestinal Colonization of Zebrafish.大肠杆菌的葡萄糖代谢抑制霍乱弧菌在斑马鱼肠道的定植。
Infect Immun. 2018 Nov 20;86(12). doi: 10.1128/IAI.00486-18. Print 2018 Dec.
本文引用的文献
1
Feasibility and effectiveness of oral cholera vaccine in an urban endemic setting in Bangladesh: a cluster randomised open-label trial.孟加拉国城市流行地区口服霍乱疫苗的可行性和有效性：一项整群随机开放标签试验。
Lancet. 2015 Oct 3;386(10001):1362-1371. doi: 10.1016/S0140-6736(15)61140-0. Epub 2015 Jul 9.
2
Updated global burden of cholera in endemic countries.流行国家霍乱的全球负担最新情况。
PLoS Negl Trop Dis. 2015 Jun 4;9(6):e0003832. doi: 10.1371/journal.pntd.0003832. eCollection 2015.
3
Effectiveness of an oral cholera vaccine campaign to prevent clinically-significant cholera in Odisha State, India.印度奥里萨邦口服霍乱疫苗接种运动预防具有临床意义的霍乱的效果。
Vaccine. 2015 May 15;33(21):2463-9. doi: 10.1016/j.vaccine.2015.03.073. Epub 2015 Apr 4.
4
Effectiveness of oral cholera vaccine in Haiti.
Lancet Glob Health. 2015 Mar;3(3):e120-1. doi: 10.1016/S2214-109X(15)70015-X.
5
Comparative effectiveness of different strategies of oral cholera vaccination in bangladesh: a modeling study.孟加拉国不同口服霍乱疫苗接种策略的比较效果：一项建模研究。
PLoS Negl Trop Dis. 2014 Dec 4;8(12):e3343. doi: 10.1371/journal.pntd.0003343. eCollection 2014 Dec.
6
Killed oral cholera vaccines: history, development and implementation challenges.灭活口服霍乱疫苗：历史、发展及实施挑战
Ther Adv Vaccines. 2014 Sep;2(5):123-36. doi: 10.1177/2051013614537819.
7
Use of Vibrio cholerae vaccine in an outbreak in Guinea.在几内亚的疫情中使用霍乱弧菌疫苗。
N Engl J Med. 2014 May 29;370(22):2111-20. doi: 10.1056/NEJMoa1312680.
8
Embracing oral cholera vaccine--shifting response to cholera.接受口服霍乱疫苗——转变对霍乱的应对方式
N Engl J Med. 2014 May 29;370(22):2067-9. doi: 10.1056/NEJMp1402837.
9
Cholera outbreaks in India.印度霍乱疫情。
Curr Top Microbiol Immunol. 2014;379:49-85. doi: 10.1007/82_2014_368.
10
Mass vaccination with a new, less expensive oral cholera vaccine using public health infrastructure in India: the Odisha model.在印度利用公共卫生基础设施大规模接种新型、廉价口服霍乱疫苗：奥里萨邦模式。
PLoS Negl Trop Dis. 2014 Feb 6;8(2):e2629. doi: 10.1371/journal.pntd.0002629. eCollection 2014 Feb.
Zotero 插件